{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:29:58Z","timestamp":1777879798269,"version":"3.51.4"},"reference-count":25,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2020-05488"],"award-info":[{"award-number":["RGPIN-2020-05488"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","award":["Tier 2 CIHR Canada Research Chair"],"award-info":[{"award-number":["Tier 2 CIHR Canada Research Chair"]}],"id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000029","name":"Institute of Gender and Health","doi-asserted-by":"publisher","award":["46475"],"award-info":[{"award-number":["46475"]}],"id":[{"id":"10.13039\/501100000029","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Psychopharmacology"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Oral contraceptives (OC) offer a range of ethinyl estradiol (EE) doses and progestin types, with evidence indicating marked differences in cognitive and emotional abilities in OC users. However, it remains unclear whether dose variations in EE (low vs high) and progestin androgenicity (androgenic vs anti-androgenic) are associated with variations in cognitive and emotional abilities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Our study aimed to investigate the cognitive and emotional effects of various OC formulations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Online between-subjects experimental design.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Based on regular monophasic OC formulation use, 96 participants (26\u2009\u00b1\u20097\u2009years) were recruited and categorised into one of four groups: low EE androgenic (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u200926), high EE androgenic (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u200924), low EE anti-androgenic (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u200921) and high EE anti-androgenic (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u200925). The Repeatable Battery for the Assessment of Neuropsychological Status, emotion recognition task, and the Positive and Negative Affect Schedule were administered. Visual analogue scales were also administered to assess rejection sensitivity before and after a social exclusion task (Cyberball task). Analysis of variance (2\u2009\u00d7\u20092) models were used to compare cognitive and socio-emotional abilities between groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Anti-androgenic users demonstrated higher intensity ratings for emotional faces, and heightened feelings of insecurity after a social stressor. Overall positive and negative affect, as well as performance on objective cognitive tests, were similar across OC formulations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>In OC users, OC formulations containing an anti-androgenic progestin were associated with greater perceived intensity of emotional faces as well as heightened rejection sensitivity. However, these subtle differences in task performance did not translate to differences in overall affect or cognitive performance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/20451253251386245","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:02Z","timestamp":1761991742000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Oral contraceptive formulation and socio-cognitive performance: a short communication"],"prefix":"10.1177","volume":"15","author":[{"given":"Minhal","family":"Mussawar","sequence":"first","affiliation":[{"name":"Department of Psychology, University of Regina, Regina, SK, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sneha","family":"Chenji","sequence":"additional","affiliation":[{"name":"Department of Psychology, University of Regina, Regina, SK, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Bueno","sequence":"additional","affiliation":[{"name":"Department of Psychology, University of Regina, Regina, SK, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6401-6827","authenticated-orcid":false,"given":"Jennifer L.","family":"Gordon","sequence":"additional","affiliation":[{"name":"Department of Psychology, University of Regina, 3737 Wascana Parkway, Regina, SK S4S 0A2, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,11]]},"reference":[{"issue":"62","key":"e_1_3_4_2_2","first-page":"1","article-title":"Contraceptive methods women have ever used: United States, 1982-2010","author":"Daniels K","year":"2013","unstructured":"Daniels K, Mosher WD. Contraceptive methods women have ever used: United States, 1982-2010. Natl Health Stat Report 2013; (62): 1\u201315.","journal-title":"Natl Health Stat Report"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2890"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa003216"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-7824(99)00109-2"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2022.101052"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2022.101032"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2008.11.011"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-147-8-200710160-00010"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/arclin\/acv058"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1177\/0098628316677643"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.3758\/BF03192765"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.3758\/BRM.42.3.775"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1076\/jcen.20.3.310.823"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsycho.2013.02.001"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1024902500935"},{"key":"e_1_3_4_17_2","volume-title":"The PANAS-X: manual for the positive and negative affect schedule - expanded form","author":"Watson D","year":"1994","unstructured":"Watson D, Clark LA. The PANAS-X: manual for the positive and negative affect schedule - expanded form. Iowa: University of Iowa, 1994."},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2517-6161.1995.tb02031.x"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1011891108"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-9280.2007.01955.x"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0911700107"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2021.105604"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1177\/18344909241254499"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(02)01333-1"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1350318"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yhbeh.2015.06.012"}],"container-title":["Therapeutic Advances in Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20451253251386245","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20451253251386245","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20451253251386245","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:53:45Z","timestamp":1777593225000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20451253251386245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":25,"alternative-id":["10.1177\/20451253251386245"],"URL":"https:\/\/doi.org\/10.1177\/20451253251386245","relation":{},"ISSN":["2045-1253","2045-1261"],"issn-type":[{"value":"2045-1253","type":"print"},{"value":"2045-1261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]},"article-number":"20451253251386245"}}